Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
https://www.zacks.com/stock/news/2284592/abbott-abt-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2284592
Jun 06, 2024 - The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
0
Abbott (ABT) Stock Dips While Market Gains: Key Facts
https://www.zacks.com/stock/news/2284322/abbott-abt-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2284322
Jun 05, 2024 - In the closing of the recent trading day, Abbott (ABT) stood at $103.23, denoting a -0.19% change from the preceding trading day.
0
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
https://www.zacks.com/stock/news/2283556/dexcom-dxcm-declines-on-potential-competition-for-stelo-revised?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2283556
Jun 04, 2024 - DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
0
Abbott (ABT) Rises As Market Takes a Dip: Key Facts
https://www.zacks.com/stock/news/2281713/abbott-abt-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2281713
May 30, 2024 - The latest trading day saw Abbott (ABT) settling at $101.74, representing a +1% change from its previous close.
0
Implied Volatility Surging for Abbot Laboratories (ABT) Stock Options
https://www.zacks.com/stock/news/2280901/implied-volatility-surging-for-abbot-laboratories-abt-stock-options?cid=CS-ZC-FT-tale_of_the_tape|options-2280901
May 29, 2024 - Investors need to pay close attention to Abbot Laboratories (ABT) stock based on the movements in the options market lately.
0
Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2276552/wall-street-analysts-see-abbott-abt-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2276552
May 21, 2024 - Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
Here's Why You Should Hold on to Abbott (ABT) Stock for Now
https://www.zacks.com/stock/news/2276548/here-s-why-you-should-hold-on-to-abbott-abt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2276548
May 21, 2024 - Abbott's (ABT) share recovery in the Nutrition business buoys optimism.
0
Top Stock Reports for UnitedHealth, Danaher & Abbott
https://www.zacks.com/commentary/2275925/top-stock-reports-for-unitedhealth-danaher-abbott?cid=CS-ZC-FT-research_daily-2275925
May 20, 2024 - Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).
0
These Dividend Stocks Are an Investor's Best Friend
https://www.fool.com/investing/2024/05/16/these-dividend-stocks-are-an-investors-best-friend/?source=iedfolrf0000001
May 16, 2024 - These two healthcare stocks are well-known for their top-tier dividend programs.
0
Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix
https://www.zacks.com/commentary/2269663/q1-earnings-season-scorecard-and-fresh-analyst-reports-for-tesla-jnj-netflix?cid=CS-ZC-FT-research_daily-2269663
May 07, 2024 - Today's Research Daily features the Q1 earnings season scorecard and updated analyst reports on Tesla (TSLA), JNJ (JNJ), Netflix (NFLX) and others.
0